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The diagnosis is often correctly predicted from characteristic imaging appearances. Some meningi-
omas have atypical imaging appearance that may cause diagnostic confusion.
Aim: Is to evaluate the role of advanced MR imaging techniques in differentiating typical from
atypical and malignant meningiomas before surgery.
Patient: Thirty patients were retrospectively included in this study. They were referred from
Neurosurgery Department and all of them suspected to have intracranial meningioma according
to the contrast enhanced CT.
Methods: All patients were subjected to conventional magnetic resonance imaging followed by
advanced magnetic resonance imaging in the form of diffusion weighted imaging, perfusion
weighted imaging and MR spectroscopy by single-voxel techniques.534149/0149997245; tel.: +20
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412 H.I. Tantawy et al.Results: The overall results based on differentiation of typical from atypical and malignant menin-
giomas by advanced MRI techniques. Twenty four patients had typical meningioma and 6 patients
had atypical and malignant Meningiomas by advanced MRI techniques.
Conclusion: Appearance of meningiomas on DWIs and the calculation of ADC values could be
correlated with their histopathological grading. On MRS, alanine was not found to be increased
in all meningiomas, so MRS cannot reliably differentiate typical intracranial meningomas from
atypical meningiomas.
 2010 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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Imaging plays an integral role in intracranial lesions manage-
ment. Magnetic resonance (MR) imaging in particular has
emerged as the imaging modality most frequently used to eval-
uate intracranial lesions. In general, the role of MR imaging in
the work up of intracranial mass lesions can be broadly
divided into diagnosis, classiﬁcation, treatment planning and
post-treatment surveillance (1).
In addition to conventional MR imaging techniques, a vari-
ety of advanced techniques have found their place in clinical
practice. These advanced techniques offer more than the ana-
tomic information provided by the conventional MR imaging
sequences. They generate physiologic data and information on
chemical composition (2).
The diagnostic aim of functional neuroimaging of CNS
neoplasms is to optimize tumor characterization, with an
emphasis on improved speciﬁcity to separate benign from
malignant features. Furthermore, functional neuroimaging of
CNS neoplasms can be expanded to the monitoring of the
ongoing therapy (3).
New techniques of functional MRI can now extract physi-
ological information while presenting the high anatomic spec-
iﬁcity, opening up new possibilities in diagnostic imaging (4).
Examples of such functional imaging modalities include, diffu-
sion-weighted MR imaging (DWI) of microscopic water mo-
tion, perfusion-weighted MR imaging (PWI) of tissue blood
ﬂow parameters, and direct imaging of brain metabolites using
magnetic resonance spectroscopy (MRS) (5).
1.1. Pathology and imaging ﬁndings
Meningioma is the most common primary non-glial benign
intracranial neoplasm (6,7). It arises from the ‘‘arachnoid
cap cells’’ of the arachnoid granulations, they may originate
from the dural or pial cells (8,9).
Meningiomas are benign but locally aggressive tumor, they
are found in the following anatomic sites in descending order
of frequency: parasagittal region, ﬂax, cerebellar convexity,
olfactory groove, tuberculum sellae, sphenoid ridge, petrous
face (CPA), tertorium, lateral ventricle, clivus as well as other
sites (10).
Meningiomas predominantly occur in adults between the
ages of 40–70 years of age and tend to occur more often in wo-
men, the reported average age for females is 42 and that for
males is 52 (11).
Lesions in children and/or multiple meningiomas should
raise the suspicion of neuroﬁbromatosis type II. Multiplemeningiomas may also be seen in patients with previous radi-
ation therapy or they may be idiopathic in nature (12).
Most meningiomas are benign and classiﬁed as Grade-I
according to World Health Organization (WHO) standards.
However, subtypes such as atypical, clear cell, choroid and
malignant meningiomas display less favorable clinical out-
comes and are classiﬁed as Grades-II and -III (13).
Benign meningiomas are subdivided into four basic sub-
types: ﬁbroblastic, transitional, meningothelial (syncytial)
and angioblastic (8). Mixed forms are not uncommon. Malig-
nant meningiomas are rare, invasion of brain parenchyma is
generally considered to be evidence for malignancy (14).
Atypical and anaplastic (malignant) meningiomas are bio-
logically more aggressive tumors that account for 10–15% of
all meningiomas and are more prone to recurrence and rapid
growth. The rare tumors formerly known as ‘‘angioblastic
meningioma’’ is now designed as haemangiopericytoma of
the meninges (15).
These neoplasms are usually well encapsulated with broad
dural attachments. Adjacent bony destruction or hyperostosis
is common as intramural psammomatous calciﬁcation. Some
meningiomas are quite invasive and may extend into the dural
sinuses and skull base (16).
MRI is the mainstay of meningioma imaging because of its
superior soft tissue resolution and multiplanar capabilities.
Meningiomas range from isointense to hypointense on T1-
WIs, and from isointense to hyperintense on T2-WIs. They
can be difﬁcult to detect without the use of intravenous con-
trast media. They enhance avidly and homogenously after gad-
olinium injection, with the exception of cystic and heavily
calciﬁed lesions. Up to 72% of meningiomas also have an asso-
ciated dural tail. However, the dural tail is not speciﬁc for
meningiomas as it may be associated with other tumors such
as schwannomas, lymphoma and peripheral gliomas (17).
Imaging ﬁndings that may suggest atypical features include
heterogeneous signal intensity and enhancement pattern, large
amount of peri-tumoral edema, absence of calciﬁcation, necro-
sis and irregular margin. The ability to distinguish typical from
atypical tumors is important because of its impact on treat-
ment decision. Moreover, this distinction may also aid in
determining the aggressiveness of surgical resection and the
necessity of combined radiation therapy (18).
Most meningiomas have characteristic ﬁndings on proton
MR spectroscopy such as the presence of alanine peak. This
may enable differentiation of meningiomas from alternative
diagnosis such as schwannomas (19). Prominent choline, ab-
sence or low amount of N-acetyle aspartate (NAA) and crea-
tine, and presence of alanine are common characteristics of
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MRS (18).
Diffusion weighted imaging (DWI) provides insight into
biological and histological characteristics of brain tumors
and may distinguish brain tumor grades, presumably mainly
duo to differences in tumor cellularity and biochemical proper-
ties of extra-cellular space (20). Atypical and malignant menin-
giomas tend to have lower diffusion coefﬁcient than benign
meningiomas because of high cellularity and limited motion
in the extra-cellular space (21).
MR perfusion studies give information about neovascular-
ity and angiogenesis and it is of great value in detecting tumor
grades, so it is possible to differentiate typical and atypical
meningiomas by perfusion imaging as the atypical or malig-
nant meningiomas are characterized by more neoangiogenesis
and higher vascularity (22).2. Patient and methods
The study was conducted in Radiodiagnosis Department-
Zagazig University in the time frame of April, 2009 to March,
2010, and included 30 patients referred from Neurosurgery
Department. All of them were suspected to have intracranial
meningioma according to CT ﬁndings. Ten patients were
examined after completion of their radiotherapy course follow-
ing resection of the tumor and proved to have underlying
residual, their pre-operative MR study were done in Radiodi-
agnosis Department, Mansora University hospitals.
The patients were subjected to the following:
(1) Clinical history taking
(2) Imaging modalities:
(A) Conventional magnetic resonance imaging (MRI):
All MRI studies were done using Philips machine (01.5
Tesla). All patients were asked to get rid of any metallic subjects
as well as they were asked about any contraindication to MRI
examination (artiﬁcial heart valve, cardiac pacemaker, metallic
stents or joint prosthesis except that made of titanium). The pa-
tients were informed about the duration of the examination, the
position of the patient and the importance of being motionless.
MRI study was done with the patients in the supine position
using the standard head coil. The examination was done before
contrast administration, a scout sagittal T1-weighted view was
obtained to verify the precise position of the patient and to act
as a localizer for subsequent slices, then multiple pulse se-
quences were used to obtain axial images followed by coronal
and/or sagittal images based on the location of the pathology
encountered. In midline lesions sagittal planes were used while
in laterally located lesions coronal images were more helpful.
The contrast media used were either Omniscan or Magni-
vist [Gadolinium (Diethelene Triamine Penta acidic acid)
(‘‘Gd-DTPA’’)], it was administrated intravenously in a dose
of 0.1 mmol/kg body weight. T1-WIs was obtained immedi-
ately after the end of contrast injection.
All cases were examined using the following protocol:
(1) Sagittal T1-WI as a localizer:
*TE = 10–12 m/s
*TR = 400–600 m/s(2) Axial and coronal spin-echo sequences, short TR/TE
(T1-weighted images):
*TE = 10–12 m/s
*TR = 400–600 m/s
(3) Axial fast spin-echo, long TR/TE (T2-weighted images):
*TE = 70–90 m/s
*TR = 2800–3500 m/s
(4) Post-contrast axial, sagittal and coronal spin-echo
sequences, short TR/TE (T1-weighted images):
*TE = 10–12 m/s
*TR = 400–600 m/s
FOV= 24–18 cm in axial images and 30–22 cm in coronal
images.
Matrix (frequency · phase) 192 · 160.
Slice thickness = 6 mm with 2 mm interval. (In all
sequences.)
(B) Advanced magnetic resonance imaging:
– Diffusion-weighted imaging.
– Perfusion-weighted imaging.
– Proton MR spectroscopy.
After performing the conventional MR imaging, diffusion
MR imaging (DWI) was performed followed by perfusion
weighted imaging (PWI) and contrast enhanced T1-wighted
imaging in the axial, sagittal and coronal planes. Finally pro-
ton MR spectroscopy was performed.
(C) Diffusion-weighted MR imaging (DWI):
The imaging sequence for DWI was a multi-section single
shot spin-echo EPI sequence (TR/TE/NEX: 4200/140 ms/I)
with diffusion sensitivities of b values = 0, 500 and 1000 s/
mm2. The diffusion gradients were applied sequentially in
three orthogonal directions (X, Y and Z directions). Sections
of 5 mm thickness, interslice gap of 1 mm, FOV 240 mm and
a matrix of 128 · 256 were used for all images. The total acqui-
sition time was 80 s.
Three types were obtained; orthogonal images, trace images
and ADCmaps. The ADC maps were calculated automatically
by MRI software and included in the sequence. Measurements
of ADC were made in different regions of interest (ROI) of the
lesions and in comparable contra-lateral regions. The ADC
values were expressed in 103 mm2/s.
(D) Perfusion weighted imaging:
Perfusion weighted images were obtained using dynamic
post-contrast T2* gradient echo EPI sequence (TR/TE/NEX:
4200/47 ms/I, ﬂip angle 20 degree, slice thickness of 5 mm,
interslice gap of 1mm, FOV: 240 mm, matrix 128 · 256). A ser-
ies of 50 multi-section acquisitions was acquired at one second
intervals. The ﬁrst ten acquisitions were performed before con-
trast agent injection to establish a pre-contrast baseline. At the
tenth acquisition, a bolus of gadopentate dimeglumine (in a
double dose of 0.2 mmol/kg) was injected using an automated
injector at a rate of 5 ml/s through a 18–20 gauge intravenous
catheter inserted in an antecubital vein. This was followed by a
bolus injection of saline (total of 20 ml at 5 ml/s). So the
images were acquired before, during and after injection of
Table 1 Anatomical and pathological classiﬁcation of 30
cases of meningioma.
Site of meningioma Number
of cases
WHO classiﬁcation
Grade-I Grade-II Grade-III
Right parietal 9 8 – 1
Left parietal 6 4 1 1
Right parieto-occipital 5 5 – –
Left parieto-occipital 3 3 – –
Right temporal 3 1 1 1
Left temporal 1 2 – –
Right frontal 3 2 – –
Total number 30 25 2 3
414 H.I. Tantawy et al.gadopentate. The data acquisition time was 120 s. The
temporal resolution was sufﬁcient to monitor the passage of
bolus through the whole brain.
A region of interest (ROI) was placed carefully within the
lesion. The size of the ROIs that were chosen in a lesion varied
with the size and the shape of the lesion. When considerable
heterogeneity in enhancement pattern was observed, multiple
ROIs were used and the most enhancing areas were chosen
for the analysis. Other ROIs were placed around the circumfer-
ence of the lesion and in the contra-lateral normal hemisphere.
Time to signal intensity curve for each ROI was obtained.
The horizontal line of the curve represented the time and the
vertical line represented signal intensity that was automatically
calibrated by the machine according to the signal intensity of
the lesion.
2.1. Proton MR spectroscopy
Selection of the MR spectroscopy technique (single voxel spec-
troscopy (SVS) versus chemical shift imaging (CSI)), depended
primarily on the appearance of the lesion in the preceding pre-
and post-contrast MR images.Fig. 1 Left parietal convexity meningioma in female patient 44-ye
enhancing meningioma. (B and C): Axial DWI (b1000) and ADC map
on ADC map. The mean ADC value was 1.0 · 103 mm2/s, which is sl
image and the time to SI curve: there is mild SI loss observed in (ROI-
right parietal region (ROI-2). (F and G): SVS (TE: 270 ms): there is ob
Cho peak. Also alanine peak (Ala) is observed at 1.4 ppm.Water suppression of the dominant water signal by CHESS
technique, outer volume fat suppression as well as magnetic
shimming were performed automatically for all patients at
the beginning of both SVS and CSI examinations. Curve ﬁtting
was done automatically for all obtained spectra.
The time domain signal intensity was apodized and pro-
cessed to remove the residual water signal. Post-processingar-old. (A): Sagittal post-contrast T1-WIs: shows homogenously
: the lesion appears slightly hyperintense on DWI and hypointense
ightly more than normal brain parenchyma. (D and E): PW source
1) and around (ROI-3) the lesion compared to the SI loss from the
vious reduction in NAA and Cr peaks associated with elevation of
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phase and linear baseline corrections after Fourier transforma-
tion. In most cases, these processes were automatic. Frequency
domain curve was ﬁtted by the manufacturer to deﬁne
N-acetyle aspartate (NAA), choline-containing components
(Cho), and creatine and phosphocreatine (Cr) peaks.
Metabolic peaks used in the differentiation of different tis-
sue types were as follows: NAA at 2.02 ppm, Cho at 3.22 ppm,
Cr at 3.01 ppm, lipid containing compounds in the range of
0.9–1.3 ppm, alanine at 1.5–1.6 ppm and lactate at 1.33 ppm.
The lactate assignment was made on the basis of an inverted
doublet due to J-coupling at a TE of 135 ms.
Patient spectra were interpreted qualitatively by inspection
of the peaks and determination of any peak changes compared
to other control spectra of the same patient. Another approach
is the quantitative approach using the integral ratios.
2.1.1. Single voxel spectroscopy (SVS)
The voxel was placed in the indeterminate area identiﬁed on the
axial post-contrast T1-WIs and in a comparable contra-lateralFig. 2 Left parieto-occipital para-falcine heavily calciﬁed meningiom
of the lesion (because of the susceptibility effect of calciﬁcation) with su
WI that revealed intense enhancement of the lesion with broad enhance
DWI and ADC map showing low signal intensity of the lesion due to s
value. (f): Time to signal intensity curve showing mild signal intensity l
copes with hypoperfusion due to low vascularity of the lesion. (G): SV
NAA and Cr levels with mild elevated Cho peak. No alanine peak (Aregion. Voxel size was chosen to provide adequate signal and to
be small enough to prevent partial volume averaging of adja-
cent structures. Voxel sizes varied between 1.5 and 2 ccm.
Point resolved spectroscopy (PRESS) pulse sequence was
used for volume localization, because of its improved S/N
ratio, less sensitivity to motion and to multiple quantum
effects. The parameters used for PRESS pulse sequences were;
TR: 1500 ms, TE: 135 and/or 270 ms, spectral width: 2500 Hz
and number of points 2048. Each spectrum was acquired in
about 3 min.
3. Results
The 30 patients included in our study were classiﬁed into 24
patients had typical meningioma and the 6 patients had atyp-
ical and malignant meningiomas according to the DWI which
were correlated with histopathologic data after surgical resec-
tion of the tumor (Table 1).
Histopathological grading of meningiomas was based on
WHO classiﬁcation: Grade-I (typical meningioma), Grade-IIa in 11-year-old boy. (A) Axial T2-WI showing low signal intensity
rrounding edema. (B and C): Post-Gd-DTPA axial and sagittal T1-
d meningeal base, more evident on sagittal image. (D and E): Axial
usceptibility effect of calciﬁcation with marked reduction in ADC
oss compared to the contra-lateral normal brain parenchyma, this
S (TE: 135 m/s): The meningioma shows marked reduction in the
la) was detected.
Fig. 3 Right parietal convexity malignant meningioma in 53-
year-old female patient presented by persistent headache. (A and
B): sagittal T1-WI and Axial T2WI: show right parietal convexity
meningioma. (C and D) Axial DWI (b1000) and ADC map: the
lesion appears heterogeneously hyperintense on DWI and hypo-
intense on ADC map. The mean ADC value was 0.4 · 103 mm2/
s. which is lower than normal brain parenchyma. This correlates
more with malignant meningioma. (E and F): SVS (TE: 270 ms):
there is obvious reduction in NAA and Cr peaks associated with
elevation of Cho peak. No alanine peak could be observed.
416 H.I. Tantawy et al.(atypical meningioma) and Grade-III (malignant meningioma)
(Table 1). Histopathological examination revealed typical
meningiomas (n= 25), Figs. 1 and 2 and malignant meningio-
mas (n= 5), Figs. 3 and 4 (Table 1).
Twenty-nine of the thirty cases included in this study
showed typical conventional MR features of meningioma as
they displayed homogenous to intermediate signal intensity
on T1-WI and exhibited intense homogeneous enhancement
on post-Gd-DTPA images with no evidence of cystic changes,
hemorrhage or brain invasion. Calciﬁcation was detected in
eight cases (Table 2). One case displayed atypical MR features
of meningioma including large amount of peri-lesional edema,
absence of calciﬁcation, necrosis, irregular margins, and heter-
ogeneous enhancement.
3.1. Diffusion-weighted MR imaging
All cases of typical meningiomas (n= 24) appeared isointense
or slightly hyperintense on DWIs obtained at b0 and b1000.
The ADC values ranged from 0.72 to 1.8 · 103 mm2/s. One
meningioma showed marked decrease in the ADC. This
meningioma was densely calciﬁed on CT and MR images.
The decreased ADC may thus relate to the paramagnetic prop-
erties of calciﬁcation.
The suspected atypical and malignant meningiomas (n= 6)
appeared hyperintense on DWIs obtained at b0 and b1000.
The ADC values were lower than normal brain ranged from
0.42 to 0.69 · 103 mm2/s (Table 3).
3.2. Perfusion-weighted MR imaging
In the time to SI curves, mild SI loss was seen in 15 cases, mod-
erate increase in SI loss was seen in nine cases, whereas marked
increase in SI loss was seen in the six cases of suspected to be
atypical and malignant meningioma.
3.3. MR spectroscopy
All meningiomas showed decrease of (n= 23) or absence
(n= 7) of NAA. Cho was markedly increased in all cases.
Alanine resonance was observed at 1.4 ppm in 19 patients.
The statistical data results of conventional MRI and ad-
vanced MRI imaging technique versus histopathology are
demonstrated in Table 4.
The validity of advanced MRI (DWI and ADC) in distin-
guishing atypical and malignant meningioma was as follow,
sensitivity (83.3), speciﬁcity (95.8), PVP (83.3), PVN (95.8).
4. Discussion
Intracranial brain SOLs are a signiﬁcant health problem and
present several imaging challenges. The role of imaging is no
longer limited to the merely providing anatomic details.
Sophisticated magnetic resonance imaging techniques allow in-
sight into such processes as the freedom of water molecule
movement, the microvascular integrity and the hemodynamic
characteristics as well as the chemical makeup of certain com-
pounds of masses (23).
Conventional MR techniques continue to have important
limitations including; inability to reliably differentiate between
brain abscess and cystic or necrotic brain tumor, cannotdistinguish high-grade from low-grade tumors, cannot deter-
mine the exact limits of tumor extension and unable to
discriminate between typical and atypical meningiomas (17).
Meningiomas are commonly occurring-benign tumors
that constitute approximately 20% of all intracranial tumors
and are easily diagnosed during routine MR imaging. On
the other hand, atypical and malignant meningiomas,
although relatively uncommon and accounting for approxi-
mately 7.2% and 2.4%, respectively, are associated with less
favorable clinical outcome because they are more prone to
recurrence and aggressive growth. To date, investigators
have been un-successful when attempting to predict the his-
tologic types of meningiomas pre-operatively and hence
there is no reliable way to distinguish benign from atypical
or malignant meningiomas on routine MR images (13). In
the current study, which included 30 patients who had
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MRI ﬁndings cannot differentiate between typical versus
atypical and malignant tumor types in agreement with Louis
et al. (13).
In this study, most of the meningiomas (n= 24), were be-
nign according to DWI and ADC imaging correlated with his-
topathological examination. According to the WHO
classiﬁcation of meningiomas, those meningiomas with low
risk of recurrence and aggressive growth are classiﬁed as
WHO Grade-I, which includes the most common types of
meningiomas (ﬁbroblastic, transitional, or mixed and men-
ingothelial). Atypical variants of meningiomas (Grade-II) are
classiﬁed based on WHO classiﬁcation, when there is increased
in mitotic activity, increased cellularity and foci of spontane-
ous or geographic necrosis (22).
In our study, it seemed that the calculation of ADC values
could be correlated with the histopathological type ofFig. 4 Right parietal convexity malignant meningioma in 66-year-
intense enhancement of the lesion with broadly enhanced meningeal bas
intensity of the lesion on DWI and low signal intensity on ADC denoti
(D): Time to signal intensity curve showing marked SI loss (interrupt
with neovascularity and high perfusion. (E): SVS (TE = 270 m/s): The
peak. No obvious elevation in Ala.meningiomas. For example, all the 24 benign meningiomas had
ADC values above 1.0 · 103 mm2/s. All except one of these
benign meningiomas in our series had elevated ADC values
comparedwith normal brain parenchyma.Only onemeningioma
showed marked decrease in the ADC. This meningioma was
densely calciﬁed on CT and MR images. The decreased ADC
may thus relate to the paramagnetic properties of calciﬁcation.
Atypical and malignant meningiomas (n= 6), classiﬁed as
(WHO Grade-II and Grade-III, respectively), all had markedly
increased signal on DWIs, and extremely low ADC (0.42–
0.69 · 103 mm2/s) on the ADC maps, indicative of marked
restriction to water diffusion in consistence with Pavlisa et
al. (24) whom stated that high-grade tumors with increased cel-
lularity have lower ADC values than low-grade tumors or nor-
mal brain.
Five cases from these six cases of atypical and malignant
meningiomas had imaging characteristics suggestive of benignold female patient. (A): Post-Gd-DTPA sagittal T1-WI showing
e. (B and C): Axial DWI (b= 1000) and ADC showing high signal
ng restriction of diffusion that copes with high tumoral cellularity.
ed curve), compared to the contra-lateral side, which is consistent
re is obvious reduction in NAA and Cr, marked elevation of Cho
Table 2 Prediction of typical versus atypical and malignant meningiomas by conventional MRI and DWIs compared to
histopathology.
Prediction Conventional MRI with contrast DWI and ADC Histopathology
Typical meningioma 29 cases 24 cases 25
Atypical and malignant meningioma 1 case 6 cases 5
Table 3 The DWI ﬁndings in the examined cases lesions (n= 30).
Diagnoses No. of patients SI on DWIs (b0) SI on DWIs (b1000) Range of ADC (103 mm2/s)
Typical meningioma 11 Isointense Isointense 0.72–1.8
13 Slightly hyperintense Slightly hyperintense
Atypical and malignant meningioma 6 Hyperintense Hyperintense 0.42–0.69
Table 4 The statistical results of conventional MRI and advanced MR imaging in prediction of typical meningioma versus atypical
and malignant meningioma compared to histopathology.
Modality Sensitivity (%) Speciﬁcity (%) Positive predictive value (%) Negative predictive value (%) Accuracy (%)
Conventional MRI 16.7 100 100 82.7 83.5
DWI and ADC 83.3 95.8 83.3 95.8 93.3
418 H.I. Tantawy et al.nature, which included homogenous signal intensity similar to
that of gray matter, intense homogenous enhancement (no cys-
tic/necrotic/hemorrhagic foci), smooth and distinctive mar-
gins, and no evidence of brain invasion. The histopathologic
results of atypical and malignant meningiomas were not antic-
ipated on the bases of routine MR imaging. It seemed that the
histopathologic ﬁndings of these atypical and malignant
meningiomas correlated well with their appearance on DWIs
and the value of the calculated ADC, which was in agreement
with Filippi et al. (21).
Our perfusion weighted ﬁndings showed marked signal
intensity loss in six cases of atypical and malignant meningio-
mas and mild signal intensity loss in 15 typical meningiomas
and moderate signal intensity loss in the other nine cases when
compared to the contra-lateral normal appearing white matter.
Perfusion MR imaging data has previously been shown to
be useful in differentiating gliomas of different grades. How-
ever, these measurements are based on intravascular indicator
theory, which assumes that the contrast agent remains intra-
vascular. Because meningiomas lack a true blood-brain bar-
rier, this assumption is violated, and although corrections
can be applied, Yang et al. (22), noticed that rCBV measure-
ments in meningiomas are probably artiﬁcially elevated. They
found that the rCBV was 8.02 ± 4.74 in the 15 typical menin-
giomas and 10.50 ± 2.1 in the seven examined atypical menin-
giomas and hence concluded that dynamic contrast enhanced
MR perfusion imaging may have a role in the prospective
characterization of meningiomas.
ProtonMRSmay play a role in difﬁcult cases. Meningiomas
theoretically show a lack or absence of NAA because they
arise outside the central nervous system and absent neurons
and axons from most of these tumors. Cho is markedly in-
creased in meningiomas because of the dense cellularity and
increased membrane synthesis. Detection of some amino acidsas elevated glutamate (Glx) and alanine (Ala) was most
notable (25).
In our study all meningiomas showed decrease of (n= 23)
or absence of (n= 7) NAA. Cho was markedly increased in all
cases. Alanine was observed at 1.4 ppm in 19 patients only
conﬁrming what is written by and Cho et al. (25).
Many investigators consider elevation of alanine character-
istic for meningiomas. However, alanine has not been found to
be increased in all meningiomas. A possible explanation for in-
creased alanine is that in meningiomas, pyruvate kinase is
inhibited by L-alanine, resulting in an increased pool of pyru-
vate which may be converted to alanine. Alanine peak occurs
between 1.3 and 1.4 ppm and therefore, may overshadowed by
the presence of lactate. Atypical and malignant meningiomas,
or those that invade the brain, may show resonance in the loca-
tion of NAA, and differentiating them from astrocytomas may
then prove difﬁcult (18).
5. Summary and conclusion
With advent of MRI, the quality of pre-operative diagnostic
imaging has been improved dramatically and information
about histologic subtypes, vascularity and tumor’s consistency
are possible. DWI and ADC maps are not reliable in pre-oper-
ative discrimination between typical, atypical and malignant
meningiomas. The calculation of ADC value is considered as
a predictor of the histologic type of meningioma.
Prominent Choline (Cho), absent or low amount of NAA
and Cr, and presence of Ala are common characteristics of
spectral pattern of both atypical and typical meningiomas on
MRS. Alanine was not present in all meningioma cases, so
MRS cannot reliably differentiate between typical intracranial
meningiomas from atypical and malignant meningiomas pre-
operatively.
The role of advanced MRI techniques in differentiating typical, from atypical and malignant meningiomas 419Perfusion imaging may have a role in prospective character-
ization of the meningiomas, but cannot predict the histopath-
ologic types.Acknowledgment
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